DIAGNOS (CVE:ADK) Shares Down 5.4% – Should You Sell?

DIAGNOS Inc. (CVE:ADK) shares fell 5.4% on Monday. The stock traded as low as C$0.34 and last traded at C$0.35. Approximately 187,338 shares changed hands during trading, a decline of 18% from the average daily volume of 229,610 shares. The stock had previously closed at C$0.37.

DIAGNOS Price Performance

The firm has a market cap of C$42.36 million, a PE ratio of -8.75 and a beta of 0.40. The stock has a 50 day simple moving average of C$0.45 and a two-hundred day simple moving average of C$0.31. The company has a debt-to-equity ratio of 204.05, a quick ratio of 0.68 and a current ratio of 1.49.

Insider Buying and Selling

In related news, Director Robert Dunn purchased 105,000 shares of DIAGNOS stock in a transaction that occurred on Friday, August 28th. The stock was bought at an average cost of C$0.48 per share, for a total transaction of C$50,400.00. Following the completion of the transaction, the director owned 2,679,920 shares in the company, valued at C$1,286,361.60. The trade was a 4.08% increase in their ownership of the stock. Insiders bought 433,571 shares of company stock worth $146,400 over the last quarter. 16.81% of the stock is owned by company insiders.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.